Gross Margin
56.71%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 54.26%.Updated Aug 19, 2026Profit Margin
19.31%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
25.03%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
10.14%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
26.21%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
17.74BDKK2.75B · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
64.12DKKUpdated Aug 19, 2026Quarterly Revenue Growth
-1.60%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
9.62BDKK1.49B · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
933.00MDKK144.47M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
3.42BDKK530.33M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
-25.10%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
3.25BDKK502.92M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
1.02BDKK158.30M · vs all stocks (USD) Updated Aug 19, 20265-Year Average Dividend Yield
1.45%Updated Aug 19, 2026Payout Ratio
48.70%vs Specialty Chemicals peers Updated Aug 19, 2026Minority Interest (Equity)
0.00EURFY2025 · Dec 31, 2025Revenue
4.16BEURFY2025 · Dec 31, 2025Cost of Goods Sold
1.92BEURFY2025 · Dec 31, 2025Gross Profit
2.24BEURFY2025 · Dec 31, 2025Operating Income
882.60MEUR1.02B · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
743.40MEURFY2025 · Dec 31, 2025Income Tax Expense
159.80MEURFY2025 · Dec 31, 2025Net Income
583.60MEURFY2025 · Dec 31, 2025EBIT
811.70MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.44BEURFY2025 · Dec 31, 2025Research & Development
463.80MEURFY2025 · Dec 31, 2025Selling, General & Administrative
911.80MEURFY2025 · Dec 31, 2025Non-operating Interest Income
21.00MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
68.30MEURFY2025 · Dec 31, 2025EPS (Basic)
1.25EURFY2025 · Dec 31, 2025EPS (Diluted)
1.25EURFY2025 · Dec 31, 2025Basic Shares Outstanding
465.93MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
465.93MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
583.60MEURFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00EURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
707.30MEURFY2025 · Dec 31, 2025Free Cash Flow
317.20MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
275.30MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
583.60MEURFY2025 · Dec 31, 2025Stock-based Compensation
20.40MEURFY2025 · Dec 31, 2025Other Non-cash Items
47.30MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
56.00MEURFY2025 · Dec 31, 2025Capital Expenditures
-390.10MEURFY2025 · Dec 31, 2025Net Intangibles (CF)
-61.00MEURFY2025 · Dec 31, 2025Net Acquisitions
-1.52BEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.91BEURFY2025 · Dec 31, 2025Long-term Debt Issuance
1.72BEURFY2025 · Dec 31, 2025Long-term Debt Payments
-504.60MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-99.90MEURFY2025 · Dec 31, 2025Common Dividends Paid
-402.70MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
753.30MEURFY2025 · Dec 31, 2025